326 related articles for article (PubMed ID: 24261348)
41. Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
Polman NJ; Uijterwaal MH; Witte BI; Berkhof J; van Kemenade FJ; Spruijt JW; van Baal WM; Graziosi PG; van Dijken DK; Verheijen RH; Helmerhorst TJ; Steenbergen RD; Heideman DA; Ridder R; Snijders PJ; Meijer CJ
Int J Cancer; 2017 Jan; 140(2):423-430. PubMed ID: 27677098
[TBL] [Abstract][Full Text] [Related]
42. HPV RNA in situ hybridization can inform cervical cytology-histology correlation.
Coppock JD; Willis BC; Stoler MH; Mills AM
Cancer Cytopathol; 2018 Aug; 126(8):533-540. PubMed ID: 29975461
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM.
Wentzensen N; Follansbee S; Borgonovo S; Tokugawa D; Schwartz L; Lorey TS; Sahasrabuddhe VV; Lamere B; Gage JC; Fetterman B; Darragh TM; Castle PE
AIDS; 2012 Nov; 26(17):2185-92. PubMed ID: 23018436
[TBL] [Abstract][Full Text] [Related]
44. A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.
Kisser A; Zechmeister-Koss I
BJOG; 2015 Jan; 122(1):64-70. PubMed ID: 25208923
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
46. Association of human papillomavirus L1 capsid protein with koilocytosis, expression of p16, and Ki-67, and its potential as a prognostic marker for cervical intraepithelial neoplasia.
Chen L; Sun MJ; Shi HY; He Q; Liu DG
Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):139-45. PubMed ID: 24344500
[TBL] [Abstract][Full Text] [Related]
47. Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening.
Wentzensen N; Fetterman B; Tokugawa D; Schiffman M; Castle PE; Wood SN; Stiemerling E; Poitras N; Lorey T; Kinney W
Cancer Cytopathol; 2014 Dec; 122(12):914-20. PubMed ID: 25132656
[TBL] [Abstract][Full Text] [Related]
48. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
[TBL] [Abstract][Full Text] [Related]
49. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
50. [Clinical value of p16/Ki-67 immunocytochemical dual staining in cervical cancer screening].
Wang HR; Liao GD; Chen W; Qiao YL; Jiang Y
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):636-640. PubMed ID: 28835090
[No Abstract] [Full Text] [Related]
51. Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis.
Ferrándiz-Pulido C; Masferrer E; de Torres I; Lloveras B; Hernandez-Losa J; Mojal S; Salvador C; Morote J; Ramon y Cajal S; Pujol RM; Garcia-Patos V; Toll A
J Am Acad Dermatol; 2013 Jan; 68(1):73-82. PubMed ID: 22863066
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of p16/Ki-67 Dual-Stained Cytology in Triaging HPV-Positive Women during Cervical Cancer Screening.
Hu Y; Hong Z; Gu L; Xie L; Yang B; Dai H; Chen H; Zhang B; Huang L; Liu Z; Cheng J; Zhang Y; Zhang Y; Lin J; Qiu L; Di W
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1246-1252. PubMed ID: 32156721
[TBL] [Abstract][Full Text] [Related]
53. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
[TBL] [Abstract][Full Text] [Related]
54. The association of HPV genotype with the regression, persistence or progression of low-grade squamous intraepithelial lesions.
Silveira FA; Almeida G; Furtado YL; Cavalcanti S; Silva KS; Maldonado P; Carvalho MG
Exp Mol Pathol; 2015 Dec; 99(3):702-6. PubMed ID: 26546836
[TBL] [Abstract][Full Text] [Related]
55. Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma.
Singh M; Mockler D; Akalin A; Burke S; Shroyer A; Shroyer KR
Cancer Cytopathol; 2012 Feb; 120(1):26-34. PubMed ID: 22162342
[TBL] [Abstract][Full Text] [Related]
56. Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial.
Wright TC; Stoler MH; Ranger-Moore J; Fang Q; Volkir P; Safaeian M; Ridder R
Int J Cancer; 2022 Feb; 150(3):461-471. PubMed ID: 34536311
[TBL] [Abstract][Full Text] [Related]
57. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
Yu J; Zhu HT; Zhao JJ; Su JZ; Xia YD
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):323-326. PubMed ID: 28468038
[No Abstract] [Full Text] [Related]
58. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
59. p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening.
Magkana M; Mentzelopoulou P; Magkana E; Pampanos A; Vrachnis N; Kalafati E; Daskalakis G; Domali E; Thomakos N; Rodolakis A; Anagnou NP; Pappa KI
Anticancer Res; 2022 May; 42(5):2599-2606. PubMed ID: 35489732
[TBL] [Abstract][Full Text] [Related]
60. p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China.
Yu LL; Guo HQ; Lei XQ; Qin Y; Wu ZN; Kang LN; Zhang X; Qiao YL; Chen W
Oncotarget; 2016 Oct; 7(40):64810-64819. PubMed ID: 27588487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
